서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 14 of 14

Issue DateTitle / Author(s) / CitationFileAltmetrics
2011-07
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
DOI
2011-08
Identification of genetic factors for physical activity in Korean population through a genome-wide association study
link
2012-07
MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

Lee, H. E.; Kim, M. A.; Lee, H. S.; Jung, E-J; Yang, H-K; Lee, B. L.; Bang, Y-J; Kim, W. H.

British Journal of Cancer, Vol.107 No.2, pp.325-333

DOI
2014-02
An integrated analysis of copy number alteration and global gene expression profiling reveals potential oncogenes underlying gastric cancer
view file
2015-08
Efficacy of AUY922 in lung cancer cell lines with the acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor
view file
2015-12
MET amplification, protein expression, and mutations in pulmonary adenocarcinoma
DOI
2016-02
MET amplification, protein expression, and mutations in pulmonary adenocarcinoma
view file
2016-03
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
DOI
2016-10
Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
view fileDOI
2017-04
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics
DOI
2017-08
FOXO1 suppression–induced positive crosstalk between HER2 and MET and its effect on acquired lapatinib resistance in HER2-positive gastric cancer cells
view file
2017-08
Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
view fileDOI
2019-02
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma
DOI
2023-05
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5
DOI
1